Lyxor UCITS EuroMTS 1-3Y Investment.. (LYQ2)

Exchange: XETRA Stock Exchange • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1650487413 • EUR Government Bond - Short Term

Here are some more details about the Lyxor UCITS EuroMTS 1-3Y Investment Grade DR (XETRA:LYQ2):

Company URL: http://www.amundietf.com

Domicile: Luxembourg

Index Name: Morningstar EZN 1-3 Yr Tsy Bd GR EUR

Furthermore, this fund focuses on investment-grade bonds within the 1-3 year maturity range. It aims to provide investors with exposure to the EuroMTS market while maintaining a high credit quality. The fund's performance is tied to the Morningstar EZN 1-3 Yr Tsy Bd GR EUR index, providing a benchmark for comparing its returns against similar investments.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Lyxor UCITS EuroMTS 1-3Y Investment.. (LYQ2)

LYQ2 ETF Overview

Market Cap in USD 1,785m
Category EUR Government Bond - Short Term
TER 0.17%
IPO / Inception 2017-11-23

LYQ2 ETF Ratings

Growth 5y -2.08
Fundamental -
Dividend -
Rel. Performance vs Sector -1.88
Analysts -
Fair Price Momentum 111.09 EUR
Fair Price DCF -

LYQ2 Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

LYQ2 Growth Ratios

Growth 12m 2.30%
Growth Correlation 12m 68%
Growth Correlation 3m 15%
CAGR 5y -0.67%
Sharpe Ratio 12m -1.87
Alpha vs SP500 12m -3.29
Beta vs SP500 5y weekly 0.02
ValueRay RSI 26.57
Volatility GJR Garch 1y 1.36%
Price / SMA 50 0.06%
Price / SMA 200 0.98%
Current Volume 0.7k
Average Volume 20d 6.3k

External Links for LYQ2 ETF

Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of LYQ2 stocks?
As of April 20, 2024, the stock is trading at EUR 120.99 with a total of 669 shares traded.
Over the past week, the price has changed by +0.03%, over one month by +0.14%, over three months by +0.09% and over the past year by +2.51%.
What is the forecast for LYQ2 stock price target?
According to ValueRays Forecast Model, LYQ2 Lyxor UCITS EuroMTS 1-3Y Investment.. will be worth about 120.9 in April 2025. The stock is currently trading at 120.99. This means that the stock has a potential downside of -0.05%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 120.9 -0.05%